Frontiers in reproductive health · 2026
Intracavernosal UC-MSC secretome therapy for severe erectile dysfunction: a clinical anatomy pilot study with elastography and Doppler assessment.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Margiana Ria, Supardi Supardi, Pramesti Maria Paulina Budyandini Dyah, Suroto Heri, I'tishom Reny, Amalia Fatkhurrohmah Leo, Nugroho M Ikhsan, Pratama Andi Ahmad Thoriq, Surya Atmaja Muhammad Hidayat, Jonathan Wibowo Kristophorus, Fadhillah Muhamad Rizqy, Graciana Tania, Ramelan Wahyuning, Jusuf Ahmad Aulia
Аннотация
INTRODUCTION: Erectile dysfunction (ED) is often treated with phosphodiesterase type 5 inhibitors (PDE5i). However, some patients do not respond effectively to this treatment, making regenerative therapy a potential alternative. This study aims to evaluate the safety and efficacy of umbilical cord-derived mesenchymal stem cell (UC-MSC) secretome in patients with severe ED who are unresponsive to sildenafil therapy.
METHODS: In this clinical anatomy pilot study, 15 male patients with severe ED unresponsive to sildenafil were administered intracavernosal injections of 0.5 cc of UC-MSC secretome into each corpus cavernosum at the Andrology Clinic of RSUD Dr. Soetomo (Dr. Soetomo General Academic Hospital) in Surabaya, Indonesia, between January 2024 and May 2024 and at RS Universitas Indonesia between January 2025 and May 2025. Therapy safety was evaluated based on local bleeding, hematoma, infection, and pain, while efficacy was measured using the Erection Hardness Score (EHS), International Index of Erectile Function-5 (IIEF-5), reports of morning erections, stretched penis length (SPL), flaccid penis length (FPL), penis circumference, and Penile Doppler Color Ultrasound to evaluate peak systolic velocity (PSV), resistive index (RI), intima-media thickness (IMT), shear wave elastography (SWE), and strain ratio (SR).
RESULTS: Significant improvements were observed in EHS, IIEF-5, morning erections, SPL, FPL, penis circumference, PSV, SWE, and SR after therapy. Pain was temporary and subsided within a few minutes. No significant differences in local bleeding, hematoma, and infection were observed. There was a difference in the IMT of the cavernous artery that was not statistically significant, while RI could not be analyzed.
DISCUSSION: These findings suggest that UC-MSC secretome is safe and effective as an alternative therapy for severe ED unresponsive to sildenafil, as evidenced by significant changes in EHS, IIEF-5, morning erections, SPL, FPL, penis circumference, PSV, SWE, and SR post- therapy with the potential for temporary pain. Further research is needed to support the development of regenerative therapy for the treatment of ED unresponsive to conventional treatments.
METHODS: In this clinical anatomy pilot study, 15 male patients with severe ED unresponsive to sildenafil were administered intracavernosal injections of 0.5 cc of UC-MSC secretome into each corpus cavernosum at the Andrology Clinic of RSUD Dr. Soetomo (Dr. Soetomo General Academic Hospital) in Surabaya, Indonesia, between January 2024 and May 2024 and at RS Universitas Indonesia between January 2025 and May 2025. Therapy safety was evaluated based on local bleeding, hematoma, infection, and pain, while efficacy was measured using the Erection Hardness Score (EHS), International Index of Erectile Function-5 (IIEF-5), reports of morning erections, stretched penis length (SPL), flaccid penis length (FPL), penis circumference, and Penile Doppler Color Ultrasound to evaluate peak systolic velocity (PSV), resistive index (RI), intima-media thickness (IMT), shear wave elastography (SWE), and strain ratio (SR).
RESULTS: Significant improvements were observed in EHS, IIEF-5, morning erections, SPL, FPL, penis circumference, PSV, SWE, and SR after therapy. Pain was temporary and subsided within a few minutes. No significant differences in local bleeding, hematoma, and infection were observed. There was a difference in the IMT of the cavernous artery that was not statistically significant, while RI could not be analyzed.
DISCUSSION: These findings suggest that UC-MSC secretome is safe and effective as an alternative therapy for severe ED unresponsive to sildenafil, as evidenced by significant changes in EHS, IIEF-5, morning erections, SPL, FPL, penis circumference, PSV, SWE, and SR post- therapy with the potential for temporary pain. Further research is needed to support the development of regenerative therapy for the treatment of ED unresponsive to conventional treatments.